BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 27381867)

  • 21. A new 2-pyrone derivative, 5-bromo-3-(3-hydroxyprop-1-ynyl)-2H-pyran-2-one, synergistically enhances radiation sensitivity in human cervical cancer cells.
    Woo SJ; Kim MJ; Kim RK; Yoon CH; Lim EJ; An S; Suh Y; Song JY; Kim IG; Cho CG; Lee SJ
    Anticancer Drugs; 2012 Jan; 23(1):43-50. PubMed ID: 21849886
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Curcumin targeting the thioredoxin system elevates oxidative stress in HeLa cells.
    Cai W; Zhang B; Duan D; Wu J; Fang J
    Toxicol Appl Pharmacol; 2012 Aug; 262(3):341-8. PubMed ID: 22634334
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dimethoxycurcumin, a synthetic curcumin analogue with higher metabolic stability, inhibits NO production, inducible NO synthase expression and NF-kappaB activation in RAW264.7 macrophages activated with LPS.
    Pae HO; Jeong SO; Kim HS; Kim SH; Song YS; Kim SK; Chai KY; Chung HT
    Mol Nutr Food Res; 2008 Sep; 52(9):1082-91. PubMed ID: 18481332
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thioredoxin reductase-1 mediates curcumin-induced radiosensitization of squamous carcinoma cells.
    Javvadi P; Hertan L; Kosoff R; Datta T; Kolev J; Mick R; Tuttle SW; Koumenis C
    Cancer Res; 2010 Mar; 70(5):1941-50. PubMed ID: 20160040
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radiosensitizing effect of carboplatin and paclitaxel to carbon-ion beam irradiation in the non-small-cell lung cancer cell line H460.
    Kubo N; Noda SE; Takahashi A; Yoshida Y; Oike T; Murata K; Musha A; Suzuki Y; Ohno T; Takahashi T; Nakano T
    J Radiat Res; 2015 Mar; 56(2):229-38. PubMed ID: 25599995
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Curcumin confers radiosensitizing effect in prostate cancer cell line PC-3.
    Chendil D; Ranga RS; Meigooni D; Sathishkumar S; Ahmed MM
    Oncogene; 2004 Feb; 23(8):1599-607. PubMed ID: 14985701
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of redox modulation by inhibition of thioredoxin reductase on radiosensitivity and gene expression.
    Selenius M; Hedman M; Brodin D; Gandin V; Rigobello MP; Flygare J; Marzano C; Bindoli A; Brodin O; Björnstedt M; Fernandes AP
    J Cell Mol Med; 2012 Jul; 16(7):1593-605. PubMed ID: 22003958
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of thioredoxin reductase by curcumin analogs.
    Liu Z; Du ZY; Huang ZS; Lee KS; Gu LQ
    Biosci Biotechnol Biochem; 2008 Aug; 72(8):2214-8. PubMed ID: 18685195
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sensitization of cancer cells to radiation by selenadiazole derivatives by regulation of ROS-mediated DNA damage and ERK and AKT pathways.
    Xie Q; Zhou Y; Lan G; Yang L; Zheng W; Liang Y; Chen T
    Biochem Biophys Res Commun; 2014 Jun; 449(1):88-93. PubMed ID: 24813998
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synergistic anti-oral cancer effects of UVC and methanolic extracts of Cryptocarya concinna roots via apoptosis, oxidative stress and DNA damage.
    Chang HW; Tang JY; Yen CY; Chang HS; Huang HW; Chung YA; Chen IS; Huang MY
    Int J Radiat Biol; 2016 May; 92(5):263-72. PubMed ID: 26887975
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Curcumin synergistically enhances the radiosensitivity of human oral squamous cell carcinoma via suppression of radiation-induced NF-κB activity.
    Chiang IT; Liu YC; Hsu FT; Chien YC; Kao CH; Lin WJ; Chung JG; Hwang JJ
    Oncol Rep; 2014 Apr; 31(4):1729-37. PubMed ID: 24503718
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potentiality of syringetin for preferential radiosensitization to cancer cells.
    Bando SI; Hatano O; Takemori H; Kubota N; Ohnishi K
    Int J Radiat Biol; 2017 Mar; 93(3):286-294. PubMed ID: 27707083
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 3-Methyl pyruvate enhances radiosensitivity through increasing mitochondria-derived reactive oxygen species in tumor cell lines.
    Nishida N; Yasui H; Nagane M; Yamamori T; Inanami O
    J Radiat Res; 2014 May; 55(3):455-63. PubMed ID: 24385472
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting thioredoxin reductase by micheliolide contributes to radiosensitizing and inducing apoptosis of HeLa cells.
    Zhang J; Chen Y; Fang J
    Free Radic Biol Med; 2022 Jun; 186():99-109. PubMed ID: 35561844
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and evaluation of curcumin analogues as potential thioredoxin reductase inhibitors.
    Qiu X; Liu Z; Shao WY; Liu X; Jing DP; Yu YJ; An LK; Huang SL; Bu XZ; Huang ZS; Gu LQ
    Bioorg Med Chem; 2008 Sep; 16(17):8035-41. PubMed ID: 18678491
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Radiosensitization by celastrol is mediated by modification of antioxidant thiol molecules.
    Seo HR; Seo WD; Pyun BJ; Lee BW; Jin YB; Park KH; Seo EK; Lee YJ; Lee YS
    Chem Biol Interact; 2011 Aug; 193(1):34-42. PubMed ID: 21570383
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Piperlongumine increases sensitivity of colorectal cancer cells to radiation: Involvement of ROS production via dual inhibition of glutathione and thioredoxin systems.
    Wang H; Jiang H; Corbet C; de Mey S; Law K; Gevaert T; Feron O; De Ridder M
    Cancer Lett; 2019 May; 450():42-52. PubMed ID: 30790679
    [TBL] [Abstract][Full Text] [Related]  

  • 38. β-elemene enhances the radiosensitivity of gastric cancer cells by inhibiting Pak1 activation.
    Liu JS; Che XM; Chang S; Qiu GL; He SC; Fan L; Zhao W; Zhang ZL; Wang SF
    World J Gastroenterol; 2015 Sep; 21(34):9945-56. PubMed ID: 26379399
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of thioredoxin reductase and glutathione reductase in plumbagin-induced, reactive oxygen species-mediated apoptosis in cancer cell lines.
    Hwang GH; Ryu JM; Jeon YJ; Choi J; Han HJ; Lee YM; Lee S; Bae JS; Jung JW; Chang W; Kim LK; Jee JG; Lee MY
    Eur J Pharmacol; 2015 Oct; 765():384-93. PubMed ID: 26341012
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytotoxic and radiosensitising effects of a novel thioredoxin reductase inhibitor in breast cancer.
    Abdullah NA; Inman M; Moody CJ; Storr SJ; Martin SG
    Invest New Drugs; 2021 Oct; 39(5):1232-1241. PubMed ID: 33768386
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.